These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37679572)

  • 1. Phagocytic cooperativity by tumour macrophages.
    Maoz A; Weiskopf K
    Nat Biomed Eng; 2023 Sep; 7(9):1057-1059. PubMed ID: 37679572
    [No Abstract]   [Full Text] [Related]  

  • 2. Bacterial-mediated DNA delivery to tumour associated phagocytic cells.
    Byrne WL; Murphy CT; Cronin M; Wirth T; Tangney M
    J Control Release; 2014 Dec; 196():384-93. PubMed ID: 25466954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to use macrophages to realise the treatment of tumour.
    Zhang X; Li W; Sun J; Yang Z; Guan Q; Wang R; Li X; Li Y; Feng Y; Wang Y
    J Drug Target; 2020 Dec; 28(10):1034-1045. PubMed ID: 32603199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticle-Enabled Dual Modulation of Phagocytic Signals to Improve Macrophage-Mediated Cancer Immunotherapy.
    Zhang YR; Luo JQ; Zhang JY; Miao WM; Wu JS; Huang H; Tong QS; Shen S; Leong KW; Du JZ; Wang J
    Small; 2020 Nov; 16(46):e2004240. PubMed ID: 33107142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour macrophages as potential targets of bisphosphonates.
    Rogers TL; Holen I
    J Transl Med; 2011 Oct; 9():177. PubMed ID: 22005011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour adjacent macrophage function in experimental tumours.
    Holmberg SB; Hafström L; Jacobsson L
    Anticancer Res; 1990; 10(2A):407-9. PubMed ID: 2346314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages.
    Guerriero JL; Sotayo A; Ponichtera HE; Castrillon JA; Pourzia AL; Schad S; Johnson SF; Carrasco RD; Lazo S; Bronson RT; Davis SP; Lobera M; Nolan MA; Letai A
    Nature; 2017 Mar; 543(7645):428-432. PubMed ID: 28273064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD169(+) macrophages mediate pathological formation of woven bone in skeletal lesions of prostate cancer.
    Wu AC; He Y; Broomfield A; Paatan NJ; Harrington BS; Tseng HW; Beaven EA; Kiernan DM; Swindle P; Clubb AB; Levesque JP; Winkler IG; Ling MT; Srinivasan B; Hooper JD; Pettit AR
    J Pathol; 2016 Jun; 239(2):218-30. PubMed ID: 27174786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the histone deacetylase inhibitor 4-phenylbutyrate on the clearance of apoptotic pancreatic carcinoma cells by human macrophages.
    Welsch L; Welsch T; Dovzhanskiy DI; Felix K; Giese NA; Krysko DV; Werner J
    Int J Oncol; 2012 Feb; 40(2):427-35. PubMed ID: 22020984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGFbeta is responsible for skin tumour infiltration by macrophages enabling the tumours to escape immune destruction.
    Byrne SN; Knox MC; Halliday GM
    Immunol Cell Biol; 2008 Jan; 86(1):92-7. PubMed ID: 17768418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach.
    Zeisberger SM; Odermatt B; Marty C; Zehnder-Fjällman AH; Ballmer-Hofer K; Schwendener RA
    Br J Cancer; 2006 Aug; 95(3):272-81. PubMed ID: 16832418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SLAMF7 is critical for phagocytosis of haematopoietic tumour cells via Mac-1 integrin.
    Chen J; Zhong MC; Guo H; Davidson D; Mishel S; Lu Y; Rhee I; Pérez-Quintero LA; Zhang S; Cruz-Munoz ME; Wu N; Vinh DC; Sinha M; Calderon V; Lowell CA; Danska JS; Veillette A
    Nature; 2017 Apr; 544(7651):493-497. PubMed ID: 28424516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of antigen presentation by macrophages after phagocytosis of tumour apoptotic cells.
    Henry F; Bretaudeau L; Barbieux I; Meflah K; Gregoire M
    Res Immunol; 1998; 149(7-8):673-9. PubMed ID: 9851522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppressive factor of tumour origin against macrophage phagocytosis of Staphylococcus aureus.
    Saito H; Tomioka H
    Br J Cancer; 1980 Feb; 41(2):259-67. PubMed ID: 7189404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of annexin A2 by prostaglandin E₂ impairs phagocytic ability of peritoneal macrophages in women with endometriosis.
    Wu MH; Chuang PC; Lin YJ; Tsai SJ
    Hum Reprod; 2013 Apr; 28(4):1045-53. PubMed ID: 23340055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promotion of L1210 tumour growth by macrophages.
    Huget RP; Flad HD; Opitz HG
    Z Immunitatsforsch Immunobiol; 1978 Sep; 154(5):433-41. PubMed ID: 726547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wiskott-Aldrich syndrome protein is a key regulator of the phagocytic cup formation in macrophages.
    Tsuboi S; Meerloo J
    J Biol Chem; 2007 Nov; 282(47):34194-203. PubMed ID: 17890224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactive oxygen species-mediated cytoplasmic stiffening impairs the phagocytic ability of the macrophage.
    Agarwal M; Biswas P; Bhattacharya A; Sinha DK
    J Cell Sci; 2020 Mar; 133(5):. PubMed ID: 32005700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophages in giant cell tumours of bone.
    Wood GW; Neff JR; Gollahon KA; Gourley WK
    J Pathol; 1978 May; 125(1):53-8. PubMed ID: 722390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNF May Negatively Regulate Phagocytosis of Devil Facial Tumour Disease Cells by Activated Macrophages.
    Li X; Darby J; Lyons AB; Woods GM; Körner H
    Immunol Invest; 2019 Oct; 48(7):691-703. PubMed ID: 30663448
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.